{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:26:36Z","timestamp":1781162796609,"version":"3.54.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40520-015-0450-0","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T12:17:49Z","timestamp":1444133869000},"page":"757-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Functional decline and herpes zoster in older people: an interplay of multiple factors"],"prefix":"10.1007","volume":"27","author":[{"name":"Herpes Zoster and Functional Decline Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"450_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC et al (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82:1341\u20131349","journal-title":"Mayo Clin Proc"},{"key":"450_CR2","volume-title":"Best practice approaches to minimise functional decline in the older person across the acute, sub-acute and residential aged care settings","author":"Clinical Epidemiology and Health Services Evaluation Unit, Melbourne Health. Commissioned on behalf of the Australian Health Ministers\u2019 Advisory Council (AHMAC) by the AHMAC Care of Older Australian Working Group","year":"2004","unstructured":"Clinical Epidemiology and Health Services Evaluation Unit, Melbourne Health. Commissioned on behalf of the Australian Health Ministers\u2019 Advisory Council (AHMAC) by the AHMAC Care of Older Australian Working Group (2004) Best practice approaches to minimise functional decline in the older person across the acute, sub-acute and residential aged care settings. Victorian Government Department of Human Services, Melbourne"},{"key":"450_CR3","volume-title":"Vaccination des adultes contre le zona\u2014Place du vaccin Zostavax\u00ae","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2013","unstructured":"Haut Conseil de la Sant\u00e9 Publique (2013) Vaccination des adultes contre le zona\u2014Place du vaccin Zostavax\u00ae. Collection Avis et Rapport, Paris"},{"key":"450_CR4","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1001\/archinte.159.17.2058","volume":"159","author":"M Loeb","year":"1999","unstructured":"Loeb M, McGeer A, McArthur M et al (1999) Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 159:2058\u20132064","journal-title":"Arch Intern Med"},{"key":"450_CR5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1532-5415.2004.52205.x","volume":"52","author":"CJ B\u00fcla","year":"2004","unstructured":"B\u00fcla CJ, Ghilardi G, Wietlisbach V et al (2004) Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc 52:700\u2013706","journal-title":"J Am Geriatr Soc"},{"key":"450_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1532-5415.2006.00797.x","volume":"54","author":"L Mody","year":"2006","unstructured":"Mody L, Sun R, Bradley SF (2006) Assessment of pneumonia in older adults: effect of functional status. J Am Geriatr Soc 54:1062\u20131067","journal-title":"J Am Geriatr Soc"},{"key":"450_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1532-5415.2010.02719.x","volume":"58","author":"TY Chen","year":"2010","unstructured":"Chen TY, Anderson DJ, Chopra T et al (2010) Poor functional status is an independent predictor of surgical site infections due to methicillin-resistant Staphylococcus aureus in older adults. J Am Geriatr Soc 58:527\u2013532","journal-title":"J Am Geriatr Soc"},{"key":"450_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/ageing\/aft033","volume":"42","author":"MA Caljouwn","year":"2013","unstructured":"Caljouwn MA, Kruijdenberg SJ, de Craen AJ et al (2013) Clinically diagnosed infections predict disability in activities of daily living among the oldest-old in the general population: the Leiden 85-plus Study. Age Ageing 42:482\u2013488","journal-title":"Age Ageing"},{"key":"450_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1532-5415.2004.52492.x","volume":"52","author":"OH Torres","year":"2004","unstructured":"Torres OH, Mu\u00f1oz J, Ruiz D et al (2004) Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 52:1603\u20131609","journal-title":"J Am Geriatr Soc"},{"key":"450_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jinf.2010.08.006","volume":"61","author":"J Murcia","year":"2010","unstructured":"Murcia J, Llorens P, S\u00e1nchez-Pay\u00e1 J et al (2010) Functional status determined by Barthel index predicts community acquired pneumonia mortality in general population. J Infect 61:458\u2013464","journal-title":"J Infect"},{"key":"450_CR11","volume-title":"European social statistics","author":"Eurostat\u2014European Commission","year":"2013","unstructured":"Eurostat\u2014European Commission (2013) European social statistics, 2013th edn. Eurostat Pocketbooks, Luxembourg","edition":"2013"},{"key":"450_CR12","volume-title":"Active aging: a policy framework","author":"World Health Organisation Europe","year":"2002","unstructured":"World Health Organisation Europe (2002) Active aging: a policy framework. World Health Organization, Geneva"},{"key":"450_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1576-9887(11)70013-9","volume":"12","author":"R Gil-Prieto","year":"2011","unstructured":"Gil-Prieto R, San-Mart\u00edn M, \u00c1lvaro-Meca A et al (2011) Herpes zoster hospitalizations of patients with chronic illnesses in Spain, 1998\u20132004. Vacunas 12:95\u2013101","journal-title":"Vacunas"},{"key":"450_CR14","doi-asserted-by":"publisher","first-page":"A503","DOI":"10.1016\/j.jval.2013.08.1151","volume":"16","author":"C Blein","year":"2013","unstructured":"Blein C, Gavazzi G, Paccalin M et al (2013) Evaluation of the Herpes Zoster impact as comorbidity factor in 5 pathologies French hospital care among adults aged 50 and older. Value Health 16:A503","journal-title":"Value Health"},{"key":"450_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1086\/515205","volume":"28","author":"K Schmader","year":"1999","unstructured":"Schmader K (1999) Herpes zoster in the elderly: issues related to geriatrics. Clin Infect Dis 28:736\u2013739","journal-title":"Clin Infect Dis"},{"key":"450_CR16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ophtha.2010.10.008","volume":"118","author":"JD Ho","year":"2011","unstructured":"Ho JD, Xirasagar S, Lin HC (2011) Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. Ophthalmology 118:1076\u20131081","journal-title":"Ophthalmology"},{"key":"450_CR17","first-page":"e68","volume":"7","author":"K Iglar","year":"2013","unstructured":"Iglar K, Kopp A, Glazier RH (2013) Herpes zoster as a marker of underlying malignancy. Open Med 7:e68\u2013e73","journal-title":"Open Med"},{"key":"450_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jpain.2010.02.020","volume":"11","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader K et al (2010) Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain 11:1211\u20131221","journal-title":"J Pain"},{"key":"450_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE et al (2010) The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ 182:1731\u20131736","journal-title":"CMAJ"},{"key":"450_CR20","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1086\/522152","volume":"197","author":"K Schmader","year":"2008","unstructured":"Schmader K, Gnann JW Jr, Watson CP (2008) The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 197:S207\u2013S215","journal-title":"J Infect Dis"},{"key":"450_CR21","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1086\/342958","volume":"186","author":"M Wood","year":"2002","unstructured":"Wood M (2002) Understanding pain in herpes zoster: an essential for optimizing treatment. J Infect Dis 186:S78\u2013S82","journal-title":"J Infect Dis"},{"key":"450_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ejpain.2011.04.014","volume":"15","author":"A Benbernou","year":"2011","unstructured":"Benbernou A, Drolet M, Levin MJ et al (2011) Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources. Eur J Pain 15:1100\u20131106","journal-title":"Eur J Pain"},{"key":"450_CR23","first-page":"411","volume":"95","author":"NR Ghatak","year":"1973","unstructured":"Ghatak NR, Zimmerman HM (1973) Spinal ganglion in herpes zoster. A light and electron microscopic study. Arch Pathol 95:411\u2013415","journal-title":"Arch Pathol"},{"key":"450_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1365-2249.2003.02061.x","volume":"131","author":"M Zak-Prelich","year":"2003","unstructured":"Zak-Prelich M, McKenzie RC, Sysa-Jedrzejowska A et al (2003) Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol 131:318\u2013323","journal-title":"Clin Exp Immunol"},{"key":"450_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G et al (2010) The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 8:37","journal-title":"BMC Med"},{"key":"450_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","volume":"153","author":"D Bouhassira","year":"2012","unstructured":"Bouhassira D, Chassany O, Gaillat J et al (2012) Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50\u00a0years in general practice. Pain 153:342\u2013349","journal-title":"Pain"},{"key":"450_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","volume":"79","author":"J Katz","year":"1999","unstructured":"Katz J, Melzack R (1999) Measurement of pain. Surg Clin North Am 79:231\u2013252","journal-title":"Surg Clin North Am"},{"key":"450_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR et al (2004) Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39:342\u2013348","journal-title":"Clin Infect Dis"},{"key":"450_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan PM, Schmader K, Nikas A et al (2004) Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 5:344\u2013356","journal-title":"J Pain"},{"key":"450_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2334-14-529","volume":"14","author":"M Duracinsky","year":"2014","unstructured":"Duracinsky M, Paccalin M, Gavazzi G et al (2014) ARIZONA study: is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients? BMC Infect Dis 14:529","journal-title":"BMC Infect Dis"},{"key":"450_CR31","first-page":"571","volume":"25","author":"RE Hope-Simpson","year":"1975","unstructured":"Hope-Simpson RE (1975) Postherpetic neuralgia. J R Coll Gen Pract 25:571\u2013575","journal-title":"J R Coll Gen Pract"},{"key":"450_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0304-3959(96)03229-0","volume":"69","author":"K Higa","year":"1997","unstructured":"Higa K, Mori M, Hirata K et al (1997) Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain 69:245\u2013253","journal-title":"Pain"},{"key":"450_CR33","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.pain.2007.02.004","volume":"132","author":"W Opstelten","year":"2007","unstructured":"Opstelten W, Zuithoff NP, van Essen GA et al (2007) Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain 132:S52\u2013S59","journal-title":"Pain"},{"key":"450_CR34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","volume":"26","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Levin MJ et al (2010) A prospective study of herpes zoster severity of illness. Clin J Pain 26:656\u2013666","journal-title":"Clin J Pain"},{"key":"450_CR35","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1128\/JCM.00874-07","volume":"45","author":"ML Quinlivan","year":"2007","unstructured":"Quinlivan ML, Ayres K, Ran H et al (2007) Effect of viral load on the outcome of herpes zoster. J Clin Microbiol 45:3909\u20133914","journal-title":"J Clin Microbiol"},{"key":"450_CR36","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1002\/jmv.10316","volume":"70","author":"FT Scott","year":"2003","unstructured":"Scott FT, Leedham-Green ME, Barrett-Muir WY et al (2003) A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 70:S24\u2013S30","journal-title":"J Med Virol"},{"key":"450_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jcv.2010.10.014","volume":"50","author":"ML Quinlivan","year":"2011","unstructured":"Quinlivan ML, Ayres KL, Kelly PJ et al (2011) Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 50:130\u2013135","journal-title":"J Clin Virol"},{"key":"450_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/13550289509111018","volume":"1","author":"R Mahalingam","year":"1995","unstructured":"Mahalingam R, Wellish M, Brucklier J et al (1995) Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1:130\u2013133","journal-title":"J Neurovirol"},{"key":"450_CR39","first-page":"CD006866","volume":"15","author":"Q Li","year":"2009","unstructured":"Li Q, Chen N, Yang J et al (2009) Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 15:CD006866","journal-title":"Cochrane Database Syst Rev"},{"key":"450_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.medmal.2013.07.012","volume":"43","author":"C Rabaud","year":"2013","unstructured":"Rabaud C, Rogeaux O, Launay O et al (2013) Early antiviral treatment fails to completely prevent herpes-related pain. Med Mal 43:461\u2013466","journal-title":"Med Mal"},{"key":"450_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pain.2008.01.006","volume":"138","author":"N Attal","year":"2008","unstructured":"Attal N, Fermanian C, Fermanian J et al (2008) Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138:343\u2013353","journal-title":"Pain"},{"key":"450_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","volume":"7","author":"N Torrance","year":"2006","unstructured":"Torrance N, Smith BH, Bennett MI et al (2006) The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7:281\u2013289","journal-title":"J Pain"},{"key":"450_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","volume":"136","author":"D Bouhassira","year":"2008","unstructured":"Bouhassira D, Lant\u00e9ri-Minet M, Attal N et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380\u2013387","journal-title":"Pain"},{"key":"450_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","volume":"149","author":"DL Hoffman","year":"2010","unstructured":"Hoffman DL, Sadosky A, Dukes EM et al (2010) How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 149:194\u2013201","journal-title":"Pain"},{"key":"450_CR45","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.pain.2011.09.014","volume":"152","author":"N Attal","year":"2011","unstructured":"Attal N, Lanteri-Minet M, Laurent B et al (2011) The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152:2836\u20132843","journal-title":"Pain"},{"key":"450_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejpain.2009.03.010","volume":"14","author":"L Gormsen","year":"2010","unstructured":"Gormsen L, Rosenberg R, Bach FW et al (2010) Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 14:127","journal-title":"Eur J Pain"},{"key":"450_CR47","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/j.1532-2149.2013.00334.x","volume":"17","author":"F Radat","year":"2013","unstructured":"Radat F, Margot-Duclot A, Attal N (2013) Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study. Eur J Pain 17:1547\u20131557","journal-title":"Eur J Pain"},{"key":"450_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0885-3924(01)00267-6","volume":"21","author":"LM McCracken","year":"2001","unstructured":"McCracken LM, Iverson GL (2001) Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21:392\u2013396","journal-title":"J Pain Symptom Manage"},{"key":"450_CR49","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/JNEUROSCI.4123-07.2008","volume":"28","author":"MN Baliki","year":"2008","unstructured":"Baliki MN, Geha PY, Apkarian AV et al (2008) Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J Neurosci 28:1398\u20131403","journal-title":"J Neurosci"},{"key":"450_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1533-2500.2010.00432.x","volume":"11","author":"G Pickering","year":"2011","unstructured":"Pickering G, Leplege A (2011) Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly. Pain Pract 11:397\u2013402","journal-title":"Pain Pract"},{"key":"450_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1086\/320884","volume":"33","author":"C Chidiac","year":"2001","unstructured":"Chidiac C, Bruxelle J, Daures JP et al (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62\u201369","journal-title":"Clin Infect Dis"},{"key":"450_CR52","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J et al (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44:S1\u2013S26","journal-title":"Clin Infect Dis"},{"key":"450_CR53","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271\u20132284","journal-title":"N Engl J Med"},{"key":"450_CR54","first-page":"35","volume":"14","author":"A Volpi","year":"2007","unstructured":"Volpi A (2007) Severe complications of herpes zoster. Herpes 14:35\u201339","journal-title":"Herpes"},{"key":"450_CR55","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","volume":"115","author":"TJ Liesegang","year":"2008","unstructured":"Liesegang TJ (2008) Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 115:S3\u2013S12","journal-title":"Ophthalmology"},{"key":"450_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.mcna.2013.02.002","volume":"97","author":"KM O\u2019Connor","year":"2013","unstructured":"O\u2019Connor KM, Paauw DS (2013) Herpes zoster. Med Clin North Am 97:503\u2013522","journal-title":"Med Clin North Am"},{"key":"450_CR57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.17925\/USOR.2013.06.02.1","volume":"6","author":"A Rousseau","year":"2013","unstructured":"Rousseau A, Bourcier T, Colin J, Labetoulle M (2013) Herpes zoster ophthalmicus-diagnosis and management. US Ophthal Rev 6:119\u2013124","journal-title":"US Ophthal Rev"},{"key":"450_CR58","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","volume":"88","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Wollan PC, St Sauver JL et al (2013) Herpes Zoster eye complications: rates and trends. Mayo Clin Proc 88:562\u2013570","journal-title":"Mayo Clin Proc"},{"key":"450_CR59","first-page":"81","volume":"7","author":"J Novotn\u00fd","year":"2006","unstructured":"Novotn\u00fd J (2006) Specific issues in pharmacotherapy of the elderly. J Health Sci Manag Public Health 7:81\u201393","journal-title":"J Health Sci Manag Public Health"},{"key":"450_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2296-13-56","volume":"13","author":"J Schuling","year":"2012","unstructured":"Schuling J, Gebben H, Veehof LJ et al (2012) Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract 13:56","journal-title":"BMC Fam Pract"},{"key":"450_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3928\/0098-9134-20050901-04","volume":"31","author":"SC Frazier","year":"2005","unstructured":"Frazier SC (2005) Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 31:4\u201311","journal-title":"J Gerontol Nurs"},{"key":"450_CR62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","volume":"59","author":"Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society","year":"2011","unstructured":"Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society (2011) Summary of the updated American geriatrics society\/British geriatrics society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 59:148\u2013157","journal-title":"J Am Geriatr Soc"},{"key":"450_CR63","doi-asserted-by":"publisher","first-page":"1113, e88","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113, e88","journal-title":"Eur J Neurol"},{"key":"450_CR64","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice AS (2014) Clinical practice. Postherpetic neuralgia. N Engl J Med 371:1526\u20131533","journal-title":"N Engl J Med"},{"key":"450_CR65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.medmal.2014.10.004","volume":"44","author":"B Laurent","year":"2014","unstructured":"Laurent B, Vicaut E, Leplege A et al (2014) Prevalence and quality of life impact of postherpetic neuralgia (PHN) in French medical centers specialized in chronic pain management: the ZOCAD study. Med Mal Infect 44:515\u2013524","journal-title":"Med Mal Infect"},{"key":"450_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/TCRM.S47138","volume":"9","author":"P Bruckenthal","year":"2013","unstructured":"Bruckenthal P, Barkin RL (2013) Options for treating postherpetic neuralgia in the medically complicated patient. Ther Clin Risk Manag 9:329\u2013340","journal-title":"Ther Clin Risk Manag"},{"key":"450_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40266-014-0202-4","volume":"31","author":"G Pickering","year":"2014","unstructured":"Pickering G (2014) Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects. Drugs Aging 31:653\u2013660","journal-title":"Drugs Aging"},{"key":"450_CR68","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/papr.12079","volume":"14","author":"G Pickering","year":"2014","unstructured":"Pickering G, Pereira B, Cl\u00e8re F et al (2014) Cognitive function in older patients with postherpetic neuralgia. Pain Pract 14:E1\u2013E7","journal-title":"Pain Pract"},{"key":"450_CR69","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10865-006-9057-4","volume":"29","author":"JE Graham","year":"2006","unstructured":"Graham JE, Christian LM, Kiecolt-Glaser JK (2006) Stress, age, and immune function: toward a lifespan approach. J Behav Med 29:389\u2013400","journal-title":"J Behav Med"},{"key":"450_CR70","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1532-5415.1998.tb02751.x","volume":"46","author":"K Schmader","year":"1998","unstructured":"Schmader K, George LK, Burchett BM et al (1998) Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 46:973\u2013977","journal-title":"J Am Geriatr Soc"},{"key":"450_CR71","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1532-5415.1990.tb01497.x","volume":"38","author":"K Schmader","year":"1990","unstructured":"Schmader K, Studenski S, MacMillan J et al (1990) Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc 38:1188\u20131194","journal-title":"J Am Geriatr Soc"},{"key":"450_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcv.2012.06.020","volume":"55","author":"A Lasserre","year":"2012","unstructured":"Lasserre A, Blaizeau F, Gorwood P et al (2012) Herpes zoster: family history and psychological stress\u2014case\u2013control study. J Clin Virol 55:153\u2013157","journal-title":"J Clin Virol"},{"key":"450_CR73","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/cid\/ciu889","volume":"60","author":"R Harpaz","year":"2015","unstructured":"Harpaz R, Leung JW, Brown CJ et al (2015) Psychological stress as a trigger for herpes zoster: might the conventional wisdom be wrong? Clin Infect Dis 60:781\u2013785","journal-title":"Clin Infect Dis"},{"key":"450_CR74","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bbi.2011.02.001","volume":"25","author":"MR Irwin","year":"2011","unstructured":"Irwin MR, Levin MJ, Carrillo C et al (2011) Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun 25:759\u2013766","journal-title":"Brain Behav Immun"},{"key":"450_CR75","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1086\/514272","volume":"178","author":"M Irwin","year":"1998","unstructured":"Irwin M, Costlow C, Williams H et al (1998) Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 178:S104\u2013S108","journal-title":"J Infect Dis"},{"key":"450_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcv.2007.01.010","volume":"38","author":"A Volpi","year":"2007","unstructured":"Volpi A, Gatti A, Serafini G et al (2007) Clinical and psychosocial correlates of acute pain in herpes zoster. J Clin Virol 38:275\u2013279","journal-title":"J Clin Virol"},{"key":"450_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eurpsy.2003.10.002","volume":"19","author":"P Gorwood","year":"2004","unstructured":"Gorwood P (2004) The generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy? Eur Psychiatry 19:27\u201333","journal-title":"Eur Psychiatry"},{"key":"450_CR78","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1176\/appi.ajp.159.7.1133","volume":"159","author":"KS Kendler","year":"2002","unstructured":"Kendler KS, Gardner CO, Prescott CA (2002) Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 159:1133\u20131145","journal-title":"Am J Psychiatry"},{"key":"450_CR79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0304-3959(99)00242-0","volume":"85","author":"JW Vlaeyen","year":"2000","unstructured":"Vlaeyen JW, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85:317\u2013332","journal-title":"Pain"},{"key":"450_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0025-6196(11)63698-7","volume":"73","author":"B Sutor","year":"1998","unstructured":"Sutor B, Rummans TA, Jowsey SG et al (1998) Major depression in medically ill patients. Mayo Clin Proc 73:329\u2013337","journal-title":"Mayo Clin Proc"},{"key":"450_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00023210-200216020-00004","volume":"16","author":"W Jiang","year":"2002","unstructured":"Jiang W, Krishnan RR, O\u2019Connor CM (2002) Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 16:111\u2013127","journal-title":"CNS Drugs"},{"key":"450_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3628","volume":"11","author":"MJ Millan","year":"2012","unstructured":"Millan MJ, Agid Y, Br\u00fcne M et al (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141\u2013168","journal-title":"Nat Rev Drug Discov"},{"key":"450_CR83","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E et al (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851\u2013858","journal-title":"Lancet"},{"key":"450_CR84","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.5694\/j.1326-5377.2009.tb02274.x","volume":"190","author":"DM Clarke","year":"2009","unstructured":"Clarke DM, Currie KC (2009) Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust 190:S54\u2013S60","journal-title":"Med J Aust"},{"key":"450_CR85","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.2337\/diacare.27.9.2154","volume":"27","author":"EH Lin","year":"2004","unstructured":"Lin EH, Katon W, Von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27:2154\u20132160","journal-title":"Diabetes Care"},{"key":"450_CR86","first-page":"1037","volume":"157","author":"R H\u00e9bert","year":"1997","unstructured":"H\u00e9bert R (1997) Functional decline in old age. CMAJ 157:1037\u20131045","journal-title":"CMAJ"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-015-0450-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-015-0450-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-015-0450-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-015-0450-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T15:44:46Z","timestamp":1718120686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-015-0450-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1007\/s40520-015-0450-0","relation":{},"ISSN":["1720-8319","1720-8319"],"issn-type":[{"value":"1720-8319","type":"print"},{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]},"assertion":[{"value":"12 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have received within the past 5\u00a0years the following: NA: Reimbursement and fees for advisory boards or speakers from Pfizer, Lilly, Sanofi Pasteur, Sanofi Pasteur MSD, Grunenthal, Adir, Astra Zeneca, Astellas. CD: Reimbursement and fees for advisory board from Sanofi Pasteur MSD. GG: Reimbursement and fees for advisory board from bioM\u00e9rieux, ECDC, OMS, Pfizer, ViforPharma; lecture, training courses: Pfizer, Sanofi Pasteur, Sanofi Pasteur MSD, ViforPharma; invitations to attend national and international conferences: Sanofi Pasteur MSD, bioM\u00e9rieux, Pfizer, Janssens, Novartis; Grant support from Sanofi Pasteur MSD, bioM\u00e9rieux, Pfizer studies. PG: Reimbursement and fees for advisory board from AstraZeneca, Bristol-Myers-Squibb, Janssen, Lilly, Lundbeck, Naurex, Otsuka, Roche, Sanofi Pasteur MSD, Servier and Shire. ML: Reimbursement and fees for advisory boards or speakers bureau from Alcon, Allergan, Bausch & Lomb, Sanofi Pasteur MSD, Santen, Thea. FL: Reimbursement and fees for advisory board from Sanofi Pasteur MSD. GP: Sanofi Pasteur MSD, Gr\u00fcnenthal. KS: Grant support from Merck for zoster vaccine study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}